AzTrials
AzTrials

Ankle OsteoarthritisNCT03356951

Gait Analysis Following Total Ankle Replacement and Subtalar Fusion

An observational study of Ankle Osteoarthritis, run by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Subtalar fusion is commonly performed in post-traumatic subtalar osteoarthritis, rheumatoid arthritis, posterior tibial tendon dysfunction, tarsal coalition and primary subtalar osteoarthritis. Read more about this study

Who is it for?
Ages 20 to 80 years
Conditions the study is for
Ankle Osteoarthritis
What is being tested?
TAR through anterior approach and subtalar fusion and TAR through lateral approach and subtalar fusion
Type of treatment
Surgery or procedure
How many people
23 participants
Where
1 siteItaly
Study dates
16 Mar 2017to 29 Jun 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients who underwent simoultanous total ankle replacement and subtalar fusion

Who may be able to join

  • Patients who underwent ankle prosthesis (Hintegra ankle system, Zimmer Trabecular Metal Total Ankle) and simultaneous fusion of the subtalar joint with at least 12 months of follow-up willing and capable of adhering to postoperative clinical protocols and functional evaluations and who have signed a specific informed consent form approved by the Ethics Committee
  • Males or females aged between 20 and 80 years old.
  • Patients with diagnosis of primary not-inflammatory degenerative articular disease

Who cannot join

  • Patients with Body Mass Index (BMI)> 35.
  • Patients with active or suspected latent periprosthetic infection
  • Patients who underwent revision surgery.
  • Prosthesis of the hip, knee or ankle, homolateral or contralateral.
  • Fusion failure of subtalar joint.
  • Patients with chronic heart failure (NYHA stage> 2)
Show all 9Show fewer
  • Presence of neurological disorders, neuromuscular disorders or other major musculoskeletal pathologies
  • Cognitive deficits.
  • Impossibility to match questionnaires due to cognitive disorders or language dysfunctional disorders

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • IRCCS Galeazzi Orthopedic Hospital

    Milan, 20161

Other trials in Italy

About this study

Official title: Analysis of Patients Who Underwent Ankle Replacement and Simultaneous Subtalar Fusion by Biomechanical and Clinical Evaluation

Subtalar fusion is commonly performed in post-traumatic subtalar osteoarthritis, rheumatoid arthritis, posterior tibial tendon dysfunction, tarsal coalition and primary subtalar osteoarthritis. Patients with osteoarthritis or severe dysfunction involving both the ankle and the subtalar joint may benefit from an tibiotalocalcaneal fusion (TTC) or an ankle replacement and subtalar fusion. With the development of new prosthetic designs and of surgical techniques, total ankle replacements (TAR) became a reasonable alternative to fusion with functional and quality of life improvements. A gait analysis of patients that underwent TAR and simultaneous subtalar fusion allows to study with precision and reliability the ankle range of motion (ROM). On the contrary, in healthy subjects or in patients that underwent isolated TAR this is not possible because the ankle ROM is influenced by the ROM of the subtalar joint in such a way that it is not possible to analyze the two joints separately. Also, excluding the role of the subtalar joint, it is possible to accurately analyze and compare the consequences on ankle kinematics of two different prosthetic designs.

Read the detailed description

Patients who previously have underwent TAR and simultaneous subtalar fusion are retrospectively reviewed. Minimum follow-up after the surgery is 12 months.

Being tested
TAR through anterior approach and subtalar fusion, TAR through lateral approach and subtalar fusion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TAR through anterior approach and subtalar fusionProcedure or surgery

    Also called Hintegra ankle system

    Simultaneous total ankle replacement through anterior approach and subtalar fusion

  • TAR through lateral approach and subtalar fusionProcedure or surgery

    Also called Zimmer TM (Trabecular Metal ) Total Ankle

    Simultaneous total ankle replacement through lateral approach and subtalar fusion

Study groups in NCT03356951
Study groupRoleWhat they receive
Lateral approach groupTAR through lateral approach and subtalar fusion
Receives: Procedure: TAR through lateral approach and subtalar fusion
Anterior approach groupTAR through anterior approach and subtalar fusion
Receives: Procedure: TAR through anterior approach and subtalar fusion

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gait analysis

    Differences in functional scores obtained by Mini-lab stereophotogrammetry-based Gait Analysis for Lower Limbs

    Measured: 1 day

Secondary outcomes (3)
  1. VAS (Visual Analog Scale)

    Differences in Pain Scores on the Visual Analog Scale

    Measured: 1 day

  2. AOFAS

    Differences in Functional Scores on the American Orthopaedic Foot and Ankle Society Score

    Measured: 1 day

  3. Short Form Health Survey (SF-12)

    Differences in Health Scores on the 12-Item Short Form Health Survey

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Nov 2017
  2. Study start16 Mar 2017
  3. Primary completion29 Jun 2017
  4. Study completion29 Jun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
23 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03356951
Sponsor's protocol ID
MAT
Status last verified
Nov 2017
First submitted
19 Nov 2017
Last updated
4 Dec 2017
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Usuelli FG, Indino C, Leardini A, Manzi L, Ortolani M, Caravaggi P. Range of motion of foot joints following total ankle replacement and subtalar fusion. Foot Ankle Surg. 2021 Feb;27(2):150-155. doi: 10.1016/j.fas.2020.03.015. Epub 2020 Apr 27.

    PubMed 32381452

Questions about this trial

What is this clinical trial studying?

An observational study of Ankle Osteoarthritis, run by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gait analysis (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03356951, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in